Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Grail shares jump on study results for cancer test
6 hours ago
Diagnostics
Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot
6 hours ago
FDA+
Compounders lose case over semaglutide shortage
6 hours ago
Health Tech
CBER head Prasad adds chief medical and scientific officer to his title
8 hours ago
FDA+
Q&A: New BIO chair to steer industry through ‘existential threats’ despite FDA receptivity
8 hours ago
R&D
China
Orphan drug, PBM changes are excluded from Senate version of Trump tax bill
Yesterday
Law
FDA approves CSL’s prophylactic for severe swelling condition
Yesterday
FDA+
Fired vaccine advisors defend ACIP’s work, independence in joint editorial
Yesterday
R&D
Purdue opioid settlement gets backing from 55 attorneys general
2 days ago
Law
Eli Lilly makes all Zepbound doses available in single-dose vials
2 days ago
Marketing
AbbVie’s cancer drug fails Phase 3 combo study to treat other bone marrow diseases
2 days ago
R&D
KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’
5 days ago
FDA+
FDA's oncology adcomm to review GSK's Blenrep relaunch plans
5 days ago
FDA+
With HIV prevention under attack, how might Gilead’s new PrEP injection fare?
5 days ago
In Focus
Moderna wins expanded label for RSV shot, allowing use in at-risk, younger adults
6 days ago
FDA+
Minnesota generic drug pricing law is likely unconstitutional, appeals court rules
6 days ago
Law
Novo Nordisk plans Phase 3 trials of oral, injectable amycretin for early 2026
6 days ago
R&D
Kennedy's vaccine doubts hinge on 'inert' placebos, but experts say he misunderstands the science
6 days ago
FDA+
In surprise, FDA approves UroGen's chemo-turned-gel drug after negative adcomm vote
6 days ago
FDA+
Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases
6 days ago
R&D
FDA+
RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone
Last week
FDA+
Trump officials seek price details and weigh consumer sales as they examine most favored nation plan
Last week
Trump’s HHS urges against reviving Chamber of Commerce’s IRA lawsuit
Last week
Law
Federal officials schedule three listening sessions this summer to address drug competition
Last week
1
2
3
4
Next page
Last page